Saltar al contenido
Merck
  • Development of a surface plasmon resonance biosensor for real-time detection of osteogenic differentiation in live mesenchymal stem cells.

Development of a surface plasmon resonance biosensor for real-time detection of osteogenic differentiation in live mesenchymal stem cells.

PloS one (2011-08-06)
Yi-Chun Kuo, Jennifer H Ho, Ta-Jen Yen, How-Foo Chen, Oscar Kuang-Sheng Lee
RESUMEN

Surface plasmon resonance (SPR) biosensors have been recognized as a useful tool and widely used for real-time dynamic analysis of molecular binding affinity because of its high sensitivity to the change of the refractive index of tested objects. The conventional methods in molecular biology to evaluate cell differentiation require cell lysis or fixation, which make investigation in live cells difficult. In addition, a certain amount of cells are needed in order to obtain adequate protein or messenger ribonucleic acid for various assays. To overcome this limitation, we developed a unique SPR-based biosensing apparatus for real-time detection of cell differentiation in live cells according to the differences of optical properties of the cell surface caused by specific antigen-antibody binding. In this study, we reported the application of this SPR-based system to evaluate the osteogenic differentiation of mesenchymal stem cells (MSCs). OB-cadherin expression, which is up-regulated during osteogenic differentiation, was targeted under our SPR system by conjugating antibodies against OB-cadherin on the surface of the object. A linear relationship between the duration of osteogenic induction and the difference in refractive angle shift with very high correlation coefficient was observed. To sum up, the SPR system and the protocol reported in this study can rapidly and accurately define osteogenic maturation of MSCs in a live cell and label-free manner with no need of cell breakage. This SPR biosensor will facilitate future advances in a vast array of fields in biomedical research and medical diagnosis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Nitrato de plata, ACS reagent, ≥99.0%
Sigma-Aldrich
Sodium thiosulfate, ReagentPlus®, 99%
Sigma-Aldrich
Dexametasona, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Nitrato de plata, ReagentPlus®, ≥99.0% (titration)
Sigma-Aldrich
Ácido L-ascórbico, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
Ácido L-ascórbico, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Sodium thiosulfate, purum p.a., anhydrous, ≥98.0% (RT)
Sigma-Aldrich
Ácido L-ascórbico, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Dexametasona, ≥98% (HPLC), powder
Sigma-Aldrich
Nitrato de plata, 99.9999% trace metals basis
Sigma-Aldrich
Ácido L-ascórbico, reagent grade, crystalline
Sigma-Aldrich
Nitrato de plata, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8%
Supelco
Ácido L-ascórbico, analytical standard
Sigma-Aldrich
Ácido L-ascórbico, 99%
Sigma-Aldrich
Ácido L-ascórbico, reagent grade
Supelco
Ácido L-ascórbico, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Nitrato de plata, puriss. p.a., ≥99.5% (AT)
Sigma-Aldrich
Ácido L-ascórbico, meets USP testing specifications
Sigma-Aldrich
Sodium thiosulfate, ≥99.99% trace metals basis
Sigma-Aldrich
Nitrato de plata, meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
Sigma-Aldrich
Ácido L-ascórbico, ACS reagent, ≥99%
Sigma-Aldrich
Dexametasona, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
Nitrato de plata, BioReagent, suitable for plant cell culture, >99% (titration)
Sigma-Aldrich
Ácido L-ascórbico, FCC, FG
Sigma-Aldrich
Ácido L-ascórbico, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
Ácido L-ascórbico, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Sigma-Aldrich
Nitrato de plata, BioXtra, >99% (titration)
Sigma-Aldrich
Dexametasona, meets USP testing specifications
Sigma-Aldrich
Ácido L-ascórbico, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
Ácido L-ascórbico, tested according to Ph. Eur.